Skip to main content
Avivagen Inc. logo

Avivagen Inc. — Investor Relations & Filings

Ticker · VIV ISIN · CA05382F2026 TSXV Manufacturing
Open in API
Filings indexed 552 across all filing types
Latest filing 2020-12-15 Annual Report
Country CA Canada
Listing TSXV VIV

About Avivagen Inc.

http://www.avivagen.com

Avivagen Inc. was a life sciences corporation focused on developing and commercializing natural health products for livestock, companion animals, and humans. The company specialized in feed additives designed to support immune function and promote growth in animals, emphasizing science-based validation through clinical trials. On April 23, 2024, Avivagen Inc. filed a voluntary assignment in bankruptcy, and a trustee was appointed to manage the proceedings.

Recent filings

Filing Released Lang Actions
Annual MD&A - English.pdf
Annual Report Classification · 95% confidence The document is titled 'Summary Financial Information and Management’s Discussion and Analysis of Financial Condition and Results of Operations' for the fiscal years ended October 31, 2020 and 2019. It includes management's discussion and analysis (MD&A) of financial condition, results of operations, liquidity, capital resources, and forward-looking statements. It references audited financial statements prepared under IFRS and includes detailed discussion of business operations, risks, and financial results. The document length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The presence of MD&A and financial data for a fiscal year-end period aligns with the characteristics of an Annual Report or 10-K equivalent filing. Therefore, the document is best classified as an Annual Report (10-K). FY 2020
2020-12-15 English
Audited annual financial statements – English.pdf
Annual Report Classification · 100% confidence The document contains detailed audited financial statements for Avivagen Inc. for the fiscal year ended October 31, 2020. It includes management's statement of responsibility, an independent auditor's report with an opinion on the financial statements, notes on accounting policies, going concern disclosures, and comprehensive financial statements such as the statement of financial position, statement of total comprehensive loss, and statement of cash flows. The presence of an auditor's report and full financial statements for a fiscal year indicates this is a full annual report. The document length (15,000 characters) and content confirm it is not a brief announcement or certification but the actual report. Therefore, the filing type corresponds to an Annual Report (10-K equivalent). FY 2020
2020-12-15 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Management Certification related to Form 13-502F1, which is a regulatory form submitted to the Ontario Securities Commission concerning participation fees for reporting issuers. It includes detailed calculations of market values, participation fees, and certifications by an officer (CFO). The content is primarily a certification and fee calculation form rather than a financial report or detailed management discussion. It does not contain financial statements or substantive financial data typical of Annual Reports, Interim Reports, or Earnings Releases. It is also not an announcement or presentation but a regulatory filing with officer certification. Therefore, according to the Certification Rule and the nature of the document, it should be classified as a Regulatory Filing (RNS).
2020-12-15 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 13-501F1' and is a Management Certification related to participation fees for Class 1 and Class 3B reporting issuers, submitted to the Alberta Securities Commission. It contains officer certification statements, market value calculations, and fee details. There are no financial statements or substantive financial data typical of annual or interim reports. The primary content is a certification by an officer regarding the completeness and accuracy of the form submitted to a regulatory body. This fits the criteria for a Regulatory Filing (RNS) as it is a certification document rather than a full financial report or announcement of a report.
2020-12-15 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing additional debt financing obtained by Avivagen Inc. It details the amount, terms, and purpose of the financing, which is to support increased product sales and operating activities. There is no indication that this is a full financial report, audit, or earnings release. The content focuses on capital structure changes through debt financing, which fits the category of Capital/Financing Update. The document length is about 5,368 characters, which is consistent with a typical announcement rather than a full report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-11-25 English
News release - English.pdf
Regulatory Filings
2020-11-19 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.